• Latest Posts
Interview 13 Oct 2021

Thinking About Risk Early on Is Key for Cell Therapy Success

Cell Therapy Firm Raises €64M to Revolutionize Manufacturing

Europe’s TCR Therapy Scene Gains Traction with €40M Series B

A Year to Remember: The Biggest European Biotech News in 2020

In Depth 30 Nov 2020

Can Anti-Aging Research Keep Us Healthy in the Long Run?

ADVERTISEMENT

Kiadis’ Natural Killer Cell Therapies Earn €308M Acquisition by Sanofi

Interview 28 Sep 2020

From Big Pharma to Startup CEO: Lessons from Kymriah Developer Gaurav Shah

T-Cell Therapy Firm Wins Massive €93M Series A to Treat Solid Tumors

Record Funding for Gene and Cell Therapy Accompanies Turbulent Times

How European Startups Have Advanced Cancer T-Cell Therapy in 2020

In Depth 13 Jul 2020

The Three Obstacles Stopping Cell Therapy Becoming Mainstream

ADVERTISEMENT